The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
In a paper published in Proceedings of the National Academy of Sciences, researchers from the Technion – Israel Institute of Technology and Tel Aviv University present BetaDescribe, an AI system that translates protein sequences into natural-language descriptions, opening a new path toward understanding protein functions and accelerating drug development and material design. Protein analysis is essential in medicine and biotechnology, as demonstrated by breakthroughs such as Ozempic, a drug whose development was inspired by a peptide found in the saliva of a rare desert lizard and is used to treat obesity, diabetes and other conditions. However, experimental protein characterization remains…
Lior Jankelson is professor of medicine and biomedical engineering at NYU, where he is a Cardiac Electrophysiologist, and serves as director of the Inherited Arrhythmia Program; as well as leading the “AI in Cardiology group”. He is an entrepreneur, a surfer, and – a proud Technion Alum! In this episode we talk about AI and […]
A study published in Oncogene presents an innovative strategy for the particularly complex medical challenge of destroying aggressive, treatment-resistant tumors. The research was jointly led by early-career scientists Dr. Avital Oknin Vaisman and Dr. Deepanjan Panda from the laboratories of Prof. Amir Orian, head of the Rappaport Center for Cancer Research at the Technion – Israel Institute of Technology, and a faculty member in the Ruth and Bruce Rappaport Faculty of Medicine, and Prof. Ashraf Brik of the Schulich Faculty of Chemistry. Aggressive cancers such as bone tumors (sarcomas) and melanoma that do not respond to molecular therapies have very…
A first-of-its-kind treatment in Israel was recently performed at Rambam Health Care Campus, where specialists helped a man in his 40s detox from an extreme dependence on opioid painkillers, which had reached about 130 pills a day, in a procedure that lasted just 20 minutes. The treatment was carried out using unique Israeli technology developed by Insightec, as part of an international study underway at a small number of medical centers in the United States, and now also in Israel. “This is a new therapeutic platform that allows us to offer a range of noninvasive treatments for many problems affecting…
Seven researchers from Israel have won prestigious ERC Advanced Grants from the European Union’s Horizon Europe program, awarded to senior scientists with exceptional research achievements over the past decade. Four of the recipients are from the Weizmann Institute of Science, two are from the Hebrew University of Jerusalem, and one is affiliated with both the Technion – Israel Institute of Technology and Rambam Health Care Campus. The grants give outstanding researchers the opportunity to pursue ambitious, curiosity-driven projects that could lead to major breakthroughs. They cover a broad range of fields at the forefront of research, from life sciences and exact sciences…
A group of researchers from the Technion – Israel Institute of Technology, and the United States has reported a breakthrough in MRI scanning that could significantly improve breast cancer diagnosis, according to a paper published in Nature Communications. The researchers developed a new method, called ELITE, that accelerates and enhances MRI scans used in breast cancer imaging, a disease diagnosed in approximately 2.3 million people each year, most of them women. The approach combines artificial intelligence with advanced mathematical modeling to enable dynamic MRI imaging at what the researchers describe as unprecedented speed and accuracy. The international study brings together…
The startup company Kimba has raised $6.5 million in a Seed round. The round was led by Selva Ventures and included Resolute Ventures, Able Partners, Barrel Ventures, Palette Ventures, Supermoon Capital, Air Ventures, Beyond 22, and Fresh Fund, which was the first investor in the company. The funding was raised in two stages: $1.1 million in a pre-Seed round, followed by an additional $5.4 million in the Seed round. The company has developed an AI-based device designed to improve sleep quality through scent therapy. It was developed in collaboration with sleep and neuroscience researchers and is intended to actively enhance…
An innovative technology developed by researchers at the Technion – Israel Institute of Technology could lead to a fundamental shift in the cancer treatment paradigm. They created advanced nanoparticles that successfully halt aggressive triple-negative breast cancer tumors – without releasing a single drug molecule. The particles operate through a sophisticated interaction with the immune system, changing the rules of the game by delivering a biological message to the tumor microenvironment and to immune system cells. Published in ACS Nano, the study was led by Ph.D. candidate Ofri Vizenblit, with the assistance of Ph.D. candidate Rawan Mhajne, under the supervision of…
As robots enter hospitals and care facilities, questions remain about whether they actually make care easier for the people who give and receive it. A new Cornell Tech-led study approaches that challenge by inviting healthcare workers, long-term care residents, and community members to help design the robots themselves. Presented at the 2026 Association for Computing Machinery CHI Conference on Human Factors in Computing Systems, the research documents a 14‑week “co-design” project in which nurses, doctors, nursing center residents, artists, engineers, computer scientists, and craftsmen worked side by side to imagine and physically build robots that could ease daily burdens in…
A human ear, engineered and printed in a laboratory, may sound like science fiction — but at the Technion, it is already becoming reality. Prof. Shulamit Levenberg, a member of the Faculty of Biomedical Engineering at the Technion, has successfully developed a method to bioprint cartilage structures designed to replace undeveloped ears. Her work represents […]
Consider pancreatic cancer – the disease that killed Steve Jobs, e.g., despite the best medical technology money could buy. Approximately 467,000 to 500,000 people die from pancreatic cancer worldwide each year. It is the sixth most common cause of cancer death globally. Due to its high mortality rate and lack of early detection, the number of deaths is projected to rise significantly in the coming decades. And no new drug to treat it has gained FDA approval – for 30 years! Moreover, survival rates are bleak: Metastatic (Stage IV): 3–6 months, though recent advancements may improve this. Locally Advanced (Stage…